Mesenchymal Células-tronco may be a viable treatment option for Post Treatment Lyme Disease Syndrome (PTLDS). Stem cells have been proven to have strong anti-inflammatory properties. Through the use of large cell quantity transplants, the youthful células-tronco have a regulatory nature on the body


NBSciência

organização de pesquisa contratada